Recent 13F filings as of September 2025 show that 151 institutional investors hold a position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 30 Sep, 2025 | 24,354,291 | -667,293 | -2.67% | $79,638,532.00 |
| RA CAPITAL MANAGEMENT, L.P. | 30 Sep, 2025 | 23,555,648 | 0 | 0.00% | $77,026,969.00 |
| Avoro Capital Advisors LLC | 30 Sep, 2025 | 21,700,000 | 0 | 0.00% | $70,959,000.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 19,307,603 | 2,442,521 | 14.48% | $63,135,862.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 16,364,861 | 3,061,086 | 23.01% | $53,513,096.00 |
| FMR LLC | 30 Sep, 2025 | 14,593,412 | -1,034,410 | -6.62% | $47,720,458.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 13,383,708 | 796,008 | 6.32% | $43,764,725.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 12,849,613 | 1,955,486 | 17.95% | $42,018,234.00 |
| Siren, L.L.C. | 30 Sep, 2025 | 11,014,737 | 0 | 0.00% | $36,018,190.00 |
| Octagon Capital Advisors LP | 30 Sep, 2025 | 9,067,500 | -3,525,000 | -27.99% | $29,650,725.00 |
| Point72 Asset Management, L.P. | 30 Sep, 2025 | 7,331,470 | 13,856 | 0.19% | $23,973,907.00 |
| STATE STREET CORP | 30 Sep, 2025 | 7,236,465 | 2,098,155 | 40.83% | $23,663,241.00 |
| Vestal Point Capital, LP | 30 Sep, 2025 | 5,500,000 | 2,500,000 | 83.33% | $17,985,000.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 30 Sep, 2025 | 5,386,000 | 0 | 0.00% | $17,612,220.00 |
| Polar Capital Holdings Plc | 30 Sep, 2025 | 5,293,879 | 293,879 | 5.88% | $17,310,984.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 5,174,516 | 1,380,944 | 36.40% | $16,924,446.00 |
| BARCLAYS PLC | 30 Sep, 2025 | 5,148,112 | 4,697,611 | 1,042.75% | $16,834,325.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 4,633,522 | 1,697,794 | 57.83% | $15,151,617.00 |
| BAKER BROS. ADVISORS LP | 30 Sep, 2025 | 4,004,756 | 0 | 0.00% | $13,095,552.00 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 30 Sep, 2025 | 3,700,000 | -395,000 | -9.65% | $12,099,000.00 |